Back to search

Inocardia Limited

08573417

active
Private Limited Company
england wales
Companies House
Health Score
73 / 100

Some Concerns

25/30
Filing
10/30
Financial
38/40
Risk
  • No accounts filed in last 18 months (-5)
  • 1 outstanding charge (-2)

Details

TECHNOCENTRE, COVENTRY, CV1 2TT
Incorporated 18/06/2013

Compliance

Last accounts

30/09/2024

total exemption full

Next accounts due

30/06/2026

On track

Confirmation statement

Last: 18/06/2025

Due 02/07/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Professor Helen Maddock

director · Since 17/12/2013

UNIVERSITY LECTURER

BRITISH · ENGLAND · Age 55

Dr Jeremy Paul Billson

director · Since 23/11/2015

CEO

BRITISH · ENGLAND · Age 59

Also on 3 other boards

Mr Paul David Noon

director · Since 20/04/2017

PRO-VICE-CHANCELLOR FOR ENTERPRISE & INN

BRITISH · ENGLAND · Age 58

Persons with Significant Control

Professor Helen Maddock

25–50% shares
25–50% votes

British · England · Age 55

Technocentre, Puma Way, Coventry, CV1 2TT

Notified 19/12/2018

Coventry University Enterprises Ltd

25–50% shares
25–50% votes

The Technocentre, Priory Street, Coventry, CV1 5FB

Notified 19/12/2018

Former PSCs

Mercia Technologies Plc

Ceased 19/12/2018

Charges1 outstanding

Charge
outstanding

COVENTRY UNIVERSITY HIGHER EDUCATION CORPORATION

Created 15/02/2018Registered 21/02/2018

CompanyRankvs 1125+ SIC 72110 peers
50

Financial strength86th percentile among SIC peers · 22/25
Employees66th percentile among SIC peers · 10/15
LiquidityNo balance sheet data · 0/20
Longevity13 years trading (max 15) · 13/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
1125Inocardia Limited
59
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity13/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/09/2024

Net Worth

£311k

Balance sheet strength

Cash

£51k

Cash in the bank

Net Current Assets

—

Working capital

Current Assets

—

Current Liabilities

£341k

Fixed Assets

£0

Debtors

£2k

2avg. employees-1

Balance Sheet

Intangible assets£599k
Prepared with Silverfin

EstimatesDerived

YearCurrent Ratio
20191.49
20181.61

Derived from filed accounts. Not audited figures.